Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bone Marrow Toxicity”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Not applicableUnknownNCT01863420
What this trial is testing

The Effect of Bone Marrow-sparing Intensity-Modulated Radiotherapy to GI Cancer

Who this might be right for
Rectal CancerGastric CancerBone Marrow Toxicity+1 more
Chinese Academy of Medical Sciences 58
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Early research (Phase 1)Looking for participantsNCT04243785
What this trial is testing

BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Edgewood Oncology Inc. 80
Testing effectiveness (Phase 2)Study completedNCT00223730
What this trial is testing

Chemotherapy Toxicity Reduction Via Urea Cycle Support

Who this might be right for
Cancer
Vanderbilt University 100
Not applicableStudy completedNCT01860456
What this trial is testing

TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study

Who this might be right for
Chronic Myeloid Leukemia
University of Pisa 412
Testing effectiveness (Phase 2)UnknownNCT00882323
What this trial is testing

Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

Who this might be right for
Aplastic Anemia
The Korean Society of Pediatric Hematology Oncology 33
Testing effectiveness (Phase 2)Ended earlyNCT00040417
What this trial is testing

Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies

Who this might be right for
Sickle Cell AnemiaHemoglobinopathyThalassemia
Baylor College of Medicine 15
Testing effectiveness (Phase 2)Study completedNCT02684162
What this trial is testing

Guadecitabine and Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapsing After Allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome+2 more
M.D. Anderson Cancer Center 55
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Not applicableUnknownNCT02630056
What this trial is testing

Validate the Dosimetric Parameters That Correlate With Acute Hematologic Toxicity (HT) in Patients With Rectal Cancer

Who this might be right for
Rectal Neoplasm
Sixth Affiliated Hospital, Sun Yat-sen University 90
Large-scale testing (Phase 3)Study completedNCT01149096
What this trial is testing

Collection of Bone Marrow From Donors Treated With or Without Filgrastim

Who this might be right for
Healthy Stem Cell DonorNo Evidence of Disease
Children's Oncology Group 13
Early research (Phase 1)Study completedNCT01633229
What this trial is testing

Bone Marrow Stromal Cell Infusions for Stem Cell Transplant Complications

Who this might be right for
Graft-Versus-Host Disease
National Heart, Lung, and Blood Institute (NHLBI) 10
Not applicableActive Not RecruitingNCT04167683
What this trial is testing

Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant

Who this might be right for
Hematologic DiseasesChronic Myeloid LeukemiaAcute Myeloid Leukemia+5 more
Rigshospitalet, Denmark 144
Testing effectiveness (Phase 2)WithdrawnNCT00003407
What this trial is testing

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaMyelodysplastic Syndromes+1 more
Rush University Medical Center
Early research (Phase 1)Study completedNCT00968162
What this trial is testing

Sickle Cell Disease Conditioning for Bone Marrow Transplant

Who this might be right for
Bone Marrow TransplantationSickle Cell Disease
Emory University 8
Testing effectiveness (Phase 2)Study completedNCT00005797
What this trial is testing

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 125
Early research (Phase 1)Active Not RecruitingNCT04281199
What this trial is testing

TBI Using IMRT (VMAT or Tomotherapy) for the Prevention of Pul Toxicities in Patients Undergoing Donor SCT

Who this might be right for
Acute LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center 20
Not applicableStudy completedNCT00578630
What this trial is testing

Interindividual Genetic Variability as a Determinant of Chemotherapy Toxicity and Response in Pediatric Bone Marrow Transplantation Patients

Who this might be right for
Neoplasms
Memorial Sloan Kettering Cancer Center 128
Testing effectiveness (Phase 2)Study completedNCT00004132
What this trial is testing

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT05998408
What this trial is testing

JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure

Who this might be right for
Severe Aplastic AnemiaSingle Lineage Cytopenias, T-LGLHypoplastic MDS
National Heart, Lung, and Blood Institute (NHLBI) 145
Load More Results